Drug approvals: '08 in review. Nebivolol (Bystolic).
Laustsen
Gary
G
Oregon Health and Science University, Portland, Ore., USA.
Carrillo
Fernando
F
Johnson
Jessica
J
Smith
Cynthia
C
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D001578:Benzopyrans / Q000494:pharmacology / Q000627:therapeutic use*; D004983:Ethanolamines / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D000068577:Nebivolol
D000319:Adrenergic beta-Antagonists; D001578:Benzopyrans; D004983:Ethanolamines; D000068577:Nebivolol